No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7530000 |
chr1:152757690-152757691 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs561109415 |
chr1:152757717-152757718 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs145663382 |
chr1:152757732-152757733 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs11205105 |
chr1:152757741-152757742 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
5 |
rs536822697 |
chr1:152757777-152757778 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs115697588 |
chr1:152757781-152757782 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs576451935 |
chr1:152757790-152757791 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs539135073 |
chr1:152757835-152757836 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs558633780 |
chr1:152757866-152757867 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs79816707 |
chr1:152757894-152757895 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs540893367 |
chr1:152757905-152757906 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs560835028 |
chr1:152757979-152757980 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs531862918 |
chr1:152757982-152757983 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs574418884 |
chr1:152757996-152757997 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs59688597 |
chr1:152757997-152757998 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs563537101 |
chr1:152758000-152758001 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs141051414 |
chr1:152758025-152758026 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs545883988 |
chr1:152758128-152758129 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs114882698 |
chr1:152758151-152758152 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs528105756 |
chr1:152758235-152758236 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs190970005 |
chr1:152758283-152758284 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs375603877 |
chr1:152758376-152758377 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs567959248 |
chr1:152758425-152758426 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs551555251 |
chr1:152758428-152758429 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs546704409 |
chr1:152758452-152758453 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs530468148 |
chr1:152758453-152758454 |
Enhancers Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs550068829 |
chr1:152758468-152758469 |
Enhancers Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs182361458 |
chr1:152758493-152758494 |
Enhancers Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs150240410 |
chr1:152758518-152758519 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs11576947 |
chr1:152758519-152758520 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
31 |
rs565871121 |
chr1:152758536-152758537 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs138829831 |
chr1:152758556-152758557 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs554590632 |
chr1:152758597-152758598 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs574380527 |
chr1:152758600-152758601 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs113357477 |
chr1:152758602-152758603 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs41268482 |
chr1:152758656-152758657 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs112621117 |
chr1:152758658-152758659 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs576987390 |
chr1:152758671-152758672 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs545544952 |
chr1:152758696-152758697 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs148953236 |
chr1:152758737-152758738 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs528245065 |
chr1:152758747-152758748 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs41268484 |
chr1:152758766-152758767 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs76539966 |
chr1:152758815-152758816 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs530285219 |
chr1:152758848-152758849 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs72702899 |
chr1:152758915-152758916 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs573941290 |
chr1:152758970-152758971 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs186411349 |
chr1:152758992-152758993 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs10888516 |
chr1:152759010-152759011 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
49 |
rs138917341 |
chr1:152759086-152759087 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs559661546 |
chr1:152759184-152759185 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|